06185.HK
CanSino Biologics, Inc.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 26.36
+1.62%Margins
Gross margin
71.7%
EBITDA margin
3.1%
EBIT margin
-4.6%
Net margin
3.3%
FCF margin
-10.5%
0.8%
Return on equity
0.6%
Return on assets
-1.0%
Return on invested capital
0.18x
Asset turnover
HKD 47.0M
Cash from operations
HKD 8.72
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026